Abstract:As many proteins prioritize functionality over constancy of structure, a proteome is the shortest stave in the Liebig's barrel of cell sustainability. In this regard, both prokaryotes and eukaryotes possess abundant machinery supporting the quality of the proteome in healthy and stressful conditions. This machinery, namely chaperones, assists in folding, refolding, and the utilization of client proteins. The functions of chaperones are especially important for brain cells, which are highly sophisticated in terms of structural and functional organization. Molecular chaperones are known to exert beneficial effects in many brain diseases including one of the most threatening and widespread brain pathologies, ischemic stroke. However, whether and how they exert the antioxidant defense in stroke remains unclear. Herein, we discuss the chaperones shown to fight oxidative stress and the mechanisms of their antioxidant action. In ischemic stroke, during intense production of free radicals, molecular chaperones preserve the proteome by interacting with oxidized proteins, regulating imbalanced mitochondrial function, and directly fighting oxidative stress. For instance, cells recruit Hsp60 and Hsp70 to provide proper folding of newly synthesized proteins—these factors are required for early ischemic response and to refold damaged polypeptides. Additionally, Hsp70 upregulates some dedicated antioxidant pathways such as FOXO3 signaling. Small HSPs decrease oxidative stress via attenuation of mitochondrial function through their involvement in the regulation of Nrf- (Hsp22), Akt and Hippo (Hsp27) signaling pathways as well as mitophagy (Hsp27, Hsp22). A similar function has also been proposed for the Sigma-1 receptor, contributing to the regulation of mitochondrial function. Some chaperones can prevent excessive formation of reactive oxygen species whereas Hsp90 is suggested to be responsible for pro-oxidant effects in ischemic stroke. Finally, heat-resistant obscure proteins (Hero) are able to shield client proteins, thus preventing their possible over oxidation.

Molecular Chaperones in Stroke-Induced Immunosuppression.

Systemic immune responses after ischemic stroke: From the center to the periphery

Augmentation of Peripheral Lymphocyte-Derived Cholinergic Activity in Patients with Acute Ischemic Stroke

Perspective Review of Myeloid Immune Cell Responses and Poststroke Immunosuppression

Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections

Chaperones vs. oxidative stress in the pathobiology of ischemic stroke

Stroke-induced Immunological Alterations and Relevant Treatment Strategies

Research progress on the roles of neurovascular unit in stroke-induced immunosuppression

Disulfidptosis and its Role in Peripheral Blood Immune Cells after a Stroke: A New Frontier in Stroke Pathogenesis

Immunodepression, Infections, and Functional Outcome in Ischemic Stroke.

Characterization of the Molecular Mechanisms Underlying the Chronic Phase of Stroke in a Cynomolgus Monkey Model of Induced Cerebral Ischemia

Microglia-mediated inflammatory destruction of neuro-cardiovascular dysfunction after stroke

The Aging Immune System: A Critical Attack on Ischemic Stroke

Targeting C–C Chemokine Receptor 5: Key to Opening the Neurorehabilitation Window after Ischemic Stroke

Novel CH25H+ and OASL+ Microglia Subclusters Play Distinct Roles in Cerebral Ischemic Stroke

Molecular Dialogs Between the Ischemic Brain and the Peripheral Immune System: Dualistic Roles in Injury and Repair.

Potential Immunotherapeutic Targets on Myeloid Cells for Neurovascular Repair after Ischemic Stroke

Possible Molecular Mechanism of Β2 Adrenergic Signaling Pathway in Regulation of Inflammation after Stroke

Unraveling the protein post-translational modification landscape: Neuroinflammation and neuronal death after stroke

Age-Related Alterations in Peripheral Immune Landscape with Magnified Impact on Post-Stroke Brain

Neuroprotection from Stroke in the Absence of Mhci or Pirb